Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase: A single mode of inhibition for the three HIV enzymes?

The genome of human immunodeficiency virus type 1 (HIV-1) encodes 15 distinct proteins, three of which provide essential enzymatic functions: a reverse transcriptase (RT), an integrase (IN), and a protease (PR). Since these enzymes are all homodimers, pseudohomodimers or multimers, disruption of pro...

Descripción completa

Detalles Bibliográficos
Autores: Camarasa Rius, María José, Velázquez Díaz, Sonsoles, San Félix García, Ana, Pérez Pérez, María Jesús, Gago Badenas, Federico|||0000-0002-3071-4878
Tipo de recurso: artículo
Fecha de publicación:2006
País:España
Institución:Universidad de Alcalá (UAH)
Repositorio:e_Buah Biblioteca Digital Universidad de Alcalá
Idioma:inglés
OAI Identifier:oai:ebuah.uah.es:10017/5071
Acceso en línea:http://hdl.handle.net/10017/5071
https://dx.doi.org/10.1016/j.antiviral.2006.05.021
Access Level:acceso abierto
Palabra clave:HIV-1
Reverse transcriptase
Integrase
Protease
Ciencia
Farmacología
Science
Pharmacology
Descripción
Sumario:The genome of human immunodeficiency virus type 1 (HIV-1) encodes 15 distinct proteins, three of which provide essential enzymatic functions: a reverse transcriptase (RT), an integrase (IN), and a protease (PR). Since these enzymes are all homodimers, pseudohomodimers or multimers, disruption of protein-protein interactions in these retroviral enzymes may constitute an alternative way to achieve HIV-1 inhibition. A growing number. of dimerization inhibitors for these enzymes is being reported. This mini review summarizes some approaches that have been followed for the development of compounds that inhibit those three enzymes by interfering with the dimerization interfaces between the enzyme subunits. (c) 2006 Elsevier B.V. All rights reserved.